Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity

Bioorg Med Chem Lett. 2021 Mar 1:35:127784. doi: 10.1016/j.bmcl.2021.127784. Epub 2021 Jan 8.

Abstract

The study report on the synthesis of a series of novel quinoxaline-alkynyl derivatives that were evaluated for their activity against Mycobacterium tuberculosis (Mtb) H37RV strain. A total of 19 compounds bearing an alcohol, aldehyde, mesylate and ester groups on the alkynly group, and also containing a chloro and nitro groups at the 6-position, were prepared. Seven compounds (3c, 4a-b, 5a, 5c, 6c and 6i), were found to have MIC90 < 10 µM, while five compounds (3b, 6a, 6b, 6d and 6h) had MIC90 in the range 10-20 µM. Compounds bearing a nitro substituent in the 6-position were generally more active and demonstrated a better safety profile, when compared to the unsubstituted and 6-chloro derivatives. Of the seven most active compounds, four contained nitro group at the 6-position.

Keywords: Esterification; Mycobacterium tuberculosis; Quinoxaline-alkynyl derivatives; Sonogashira coupling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / chemistry
  • Alkynes / pharmacology*
  • Antitubercular Agents / chemical synthesis
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycobacterium tuberculosis / drug effects*
  • Quinoxalines / chemistry
  • Quinoxalines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Alkynes
  • Antitubercular Agents
  • Quinoxalines